Global Spinal Injectable Market to Reach USD 51.2 Billion by 2033, Expanding at 8.2% CAGR

The global spinal injectable market, valued at USD 23.3 billion in 2023, is projected to soar to USD 51.2 billion by 2033, with an impressive compound annual growth rate (CAGR) of 8.2% over the forecast period. This surge is driven by increasing demand for non-opioid alternatives in pain management, positioning spinal injectables as a crucial …

Spinal Injectable Market Poised for a US$ 51.2 Billion Surge by 2033

By 2023, the spinal injectable market sales is expected to be valued US$ 23.3 billion. By 2033, the market is expected to have grown to around US$ 51.2 billion, with a compound annual growth rate of 8.2%. As chronic lower back pain grows more common, the global market for spinal injectables is predicted to increase …